Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
81.00M | 86.98M | 73.33M | 112.80M | 52.33M | Gross Profit |
44.02M | 54.53M | 39.70M | 68.19M | 19.35M | EBIT |
27.52M | 32.23M | 14.41M | 49.30M | 2.40M | EBITDA |
48.38M | 53.84M | 31.94M | 64.67M | 8.73M | Net Income Common Stockholders |
22.22M | 27.50M | 10.76M | 38.22M | -26.74M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
80.05M | 63.04M | 74.97M | 97.74M | 88.47M | Total Assets |
333.57M | 318.28M | 326.40M | 349.76M | 334.79M | Total Debt |
1.45M | 1.75M | 13.91M | 4.16M | 7.64M | Net Debt |
-78.60M | -60.97M | -61.06M | -93.57M | -80.83M | Total Liabilities |
59.47M | 63.91M | 93.33M | 95.88M | 103.19M | Stockholders Equity |
274.10M | 254.37M | 233.07M | 253.88M | 231.61M |
Cash Flow | Free Cash Flow | |||
20.06M | 8.42M | 1.07M | 22.55M | 4.50M | Operating Cash Flow |
30.82M | 12.54M | 1.16M | 30.14M | 9.23M | Investing Cash Flow |
-10.74M | -3.79M | -13.74M | 10.19M | -4.72M | Financing Cash Flow |
-2.10M | -19.68M | -5.84M | -33.37M | -9.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
59 Neutral | $13.76B | 7.65 | -2.18% | 3.85% | 2.32% | -36.56% | |
58 Neutral | $2.20B | 12.68 | 8.41% | ― | -7.18% | -19.63% | |
58 Neutral | HK$15.24B | 79.69 | 1.34% | ― | 24.36% | -18.99% | |
50 Neutral | $11.38B | 30.41 | 0.79% | 1.54% | ― | ― | |
41 Neutral | HK$97.99M | ― | -12.77% | ― | -8.19% | -498.76% |
IMAX China Holding, Inc. announced that its controlling shareholder, IMAX Corporation, released its first quarter 2025 financial results and quarterly report. The financial information, prepared according to U.S. Generally Accepted Accounting Principles, is not directly comparable to IMAX China’s financial results reported under International Financial Reporting Standards. This announcement ensures that all shareholders and potential investors have equal access to the company’s financial information, providing transparency and maintaining compliance with disclosure obligations.
IMAX China Holding, Inc. has announced significant changes in its board of directors, effective April 23, 2025. Jim Athanasopoulos has resigned as an executive director and authorized representative to focus on his role at IMAX Corporation, while Daniel Wade Manwaring has been appointed as the new authorized representative. Additionally, Jiande Chen has been redesignated from an executive director to a non-executive director, and Natasha Fernandes has been appointed as a non-executive director. These changes reflect a strategic realignment within the company’s leadership, potentially impacting its strategic direction and stakeholder relations.
IMAX China Holding, Inc. has announced a new composition of its board of directors, effective April 23, 2025, with Richard Gelfond as Chairman and Daniel Manwaring as Executive Director. This restructuring of the board, which includes a mix of executive, non-executive, and independent directors, is likely to influence the company’s strategic direction and governance, potentially impacting its market positioning and stakeholder relations.
IMAX China Holding, Inc. has announced its consolidated annual results for the year ending December 31, 2024, reporting a decrease in revenues from the previous year, with a total comprehensive income of $20.3 million attributable to the owners of the company. Despite the decrease in revenue, the company managed to maintain a strong operating profit, highlighting efficient cost management and a decrease in selling, general, and administrative expenses. This announcement follows the release of financial results and an annual report by its controlling shareholder, IMAX Corporation, which may influence stakeholders’ perceptions of IMAX China’s financial health and future prospects in the entertainment market.
IMAX China Holding, Inc. announced that its subsidiaries, IMAX Shanghai Multimedia and IMAX Hong Kong, have entered into re-release service agreements with IMAX Corporation. These agreements, effective from January 2025 and lasting three years, involve IMAX Corporation providing conversion and post-production services for the re-release of films to IMAX theaters in Greater China. This move aims to enhance the company’s offerings in the region, reinforcing its market position and potentially increasing stakeholder value through expanded film availability.
IMAX China Holding, Inc. has announced that its board of directors will convene on February 19, 2025, to review and approve the final financial results for the year ended December 31, 2024. The meeting will also consider the possibility of recommending a final dividend and address any other pertinent business matters, which could have implications for the company’s financial strategy and shareholder returns.